IEQ Capital’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.31M | Buy |
33,406
+7,720
| +30% | +$533K | 0.01% | 608 |
|
|
2025
Q1 | $1.78M | Sell |
25,686
-9,745
| -28% | -$677K | 0.01% | 609 |
|
|
2024
Q4 | $3.05M | Sell |
35,431
-1,855
| -5% | -$160K | 0.03% | 394 |
|
|
2024
Q3 | $4.44M | Buy |
37,286
+2,882
| +8% | +$343K | 0.05% | 214 |
|
|
2024
Q2 | $4.91M | Buy |
34,404
+128
| +0.4% | +$18.3K | 0.07% | 185 |
|
|
2024
Q1 | $4.4M | Buy |
34,276
+4,403
| +15% | +$565K | 0.06% | 192 |
|
|
2023
Q4 | $3.09M | Buy |
29,873
+2,399
| +9% | +$248K | 0.05% | 222 |
|
|
2023
Q3 | $2.5M | Buy |
27,474
+4,246
| +18% | +$386K | 0.05% | 223 |
|
|
2023
Q2 | $1.88M | Buy |
23,228
+5,080
| +28% | +$411K | 0.04% | 277 |
|
|
2023
Q1 | $1.44M | Buy |
18,148
+1,364
| +8% | +$109K | 0.03% | 306 |
|
|
2022
Q4 | $1.14M | Buy |
16,784
+4,908
| +41% | +$332K | 0.03% | 341 |
|
|
2022
Q3 | $592K | Buy |
11,876
+2,258
| +23% | +$113K | 0.02% | 494 |
|
|
2022
Q2 | $536K | Sell |
9,618
-948
| -9% | -$52.8K | 0.02% | 459 |
|
|
2022
Q1 | $587K | Buy |
10,566
+4,800
| +83% | +$267K | 0.01% | 458 |
|
|
2021
Q4 | $323K | Sell |
5,766
-500
| -8% | -$28K | 0.01% | 569 |
|
|
2021
Q3 | $301K | Buy |
+6,266
| New | +$301K | 0.01% | 554 |
|